Methods were developed for quantitative determination of the three major metabolites of arachidonic acid in human platelets, i.e., 12L-hydroxy-5,8,10,-14-eicosatetraenoic acid (HETE), 12L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) and 8-(1-hydroxy-3-oxopropyl)-9,12L-dihydroxy-5,10-heptadecadienoic acid (PHD). Aggregation of washed platelets by thrombin was accompanied by release of 1163-2175 ng/ml of HETE, 1129-2430 ng/ml of HHT, and 998-2299 ng/ml of PHD. The amount of PGG2 (prostaglandin G2) produced as calculated from the sum of the amounts of its metabolites (HHT and PHD) was 2477-5480 ng/ml. In contrast, the amounts of PGE2 (prostaglandin E2) and PGF2. (prostaglandin F2.) released were approximately two orders of magnitude lower. In this system, the prostaglandins thus exert their biological action through the endoperoxides, which are almost exclusively metabolized to nonprostanoate structures and only to a small extent to the classical prostaglandins.
1129-2430 ng/ml of HHT, and 998-2299 ng/ml of PHD. The amount of PGG2 (prostaglandin G2) produced as calculated from the sum of the amounts of its metabolites (HHT and PHD) was 2477-5480 ng/ml. In contrast, the amounts of PGE2 (prostaglandin E2) and PGF2. (prostaglandin F2.) released were approximately two orders of magnitude lower. In this system, the prostaglandins thus exert their biological action through the endoperoxides, which are almost exclusively metabolized to nonprostanoate structures and only to a small extent to the classical prostaglandins.
Platelets from subjects given aspirin produced less than 5% of the above mentioned amounts of HHT and PHD, whereas the production of HETE was stimulated about 3- fold. This provides additional evidence for our earlier proposal tHamberg, M., Svensson, J., Wakabayashi, T. & Samuelsson, B. (1974) Proc. Nat. Acad. Sci. USA 71, 345-3491 that the anti-aggregating effect of aspirin is through inhibition of PGG2 formation.
In a recent paper (1) we showed that the prostaglandin endoperoxides, PGG2 and PGH2, in low concentrations induce aggregation of human platelets and that they are released during thrombin-induced aggregation. Together with the known effects of inhibitors of prostaglandin biosynthesis on platelets, this indicated a physiological role of endoperoxides in platelet function and gave information on the mechanism of action of, e.g., aspirin (1, 2) . With a similar technique, it was also demonstrated that aggregation induced by collagen, epinephrine, and arachidonic acid was accompanied by release of the intact endoperoxides (3) .
We recently studied the transformation of [1-'4C] (ratios between protium and deuterium forms, 0-4; y-intercept, 0.0075; slope, 1.21).
Quantitative Detemination of 1BL-Hydroxy-6,8,1O-Heptadecatrienoic Acid (HHT). The mass spectrum of the MeSi derivative of the methyl ester of HHT showed an ion of high intensity at m/e 295 (4). Accordingly, the deuterated HETE prepared as described above could be used as internal standard in quantitative determination of HHT.
Known amounts (0-35.0 nmol) of HHT were added to 17.9 nmol of deuterated HETE, the mixtures converted into the methyl ester-Me3Si derivatives and subjected to multiple-ion analysis. The intensity of the ion at m/e 295 appearing with a retention time corresponding to an equivalent chain length of C-19.3 (HHT derivative) was divided by the intensity of the ion at m/e 301 at C-21.3 (deuterated HETE derivative) and the ratios plotted against the ratios between added HHT and deuterated HETE. The standard curve obtained was linear and had a y-intercept = 0.00 and a slope = 0.56.
Quantitative Determnination of 8-(1-Hydroxy-3-oxopropy)-9,-I2L-Dihydroxy-6,1O-Heptadecadieoc Acid (PHD). [1-14C; 5,6,8,9,11,12,14,15-2H8]PHD was prepared by incubation of deuterium-and "4C-labeled arachidonic acid (specific radioactivity, 0.93 Ci/mol) with a suspension of washed human platelets followed by silicic acid chromatography (4) (Fig. 2) . The Me3Si derivative of cholesterol appeared with a retention time about 6 times longer than that of the methyl ester-Me3Si derivative of HETE. Accordingly, after five consecutive injections of the derivatives of HHT and HETE, it was necessary to interupt the injections so that the cholesterol derivatives could be'eluted. Material in the zone of PHD was also converted into MeaSi derivatives and subjected to multiple-ion analysis ( Platelet Preparation. Washed human platelets were prepared as previously described (1). Table 1 gives amounts of HETE, HHT, and PHD released during thrombin-induced aggregation (5 U/ml; 20 min) of washed platelets (288,000-756,000/&Id) obtained from eight healthy subjects before and 2 hr after ingestion of two tablets of aspirin (648 mg of acetylsalicylic acid). The ranges found were: HETE, 1163-2175 ng/ml (before aspirin) and 3622-5798 ng/ml (after aspirin); HHT, 1129-2430 ng/ml (before aspirin) and less than 23-67 ng/ml (after aspirin); PHD, 998-2299 ng/ml (before aspirin) and 17-42 ng/ml (after aspirin). The ranges of PGG2 (calculated from the sum of the amounts of HHT and PHD after correction for the different molecular weights) were 2477-5480 ng/ml (before aspirin) and less than 51-127 ng/ml (after aspirin). Also given in Table 1 are absorbancies recorded in the TBA reaction. 3 shows the effect of preincubation of platelets, with aspirin or indomethacin, on the synthesis of HETE and HHT. Formation of HHT was inhibited in the presence of both agents, whereas formation of HETE was stimulated. As can be seen in Fig. 3 , indomethacin in high concentrations appeared to have a weak inhibitory effect on the formation of HETE although the amount of HETE formed even in the presence of 100 pg/ml of indomethacin was higher than that formed in the absence of indomethacin. (4) . Again, the time courses for the formation of HHT and PHD were identical and faster than that observed for the formation of HETE.
RESULTS
In Fig. 4 , the amounts of PGE2 (34 and 28 ng/ml at 1 min; 43 and' 37 ng/ml at 5 min; upper and lower panels, respectively) and PGF2a (16 and 9 ng/ml at 1 mnin; 22 and 10 ng/ml at 5 min; upper and lower panels, respectively) were very small when compared to the amounts of HHT and PHD. The amounts of intact endoperoxide(s) (PGG2 and/or PGH2) present after 1 intensity at m/e 295, as was the case with the corresponding derivative of HETE (4), the deuterated HETE standard could be used for determination of HHT as well as HETE.
Application of the methods to platelets revealed that large amounts of HETE, HHT, and PHD were released during thrombin-induced aggregation. Washed platelets obtained from eight healthy subjects released 1163-2175 ng/ml of HETE, 1129-2430 ng/ml of HHT, and 998-2299 ng/ml of PHD after incubation at 370 for 20 min with thrombin. The calculated production of PGG2, the precursor of HHT and PHD, was 2477-5480 ng/ml. It was also found that thiobarbituric acid-positive material was produced during thrombin-induced aggregation. Although this material was not identified, its appearance together with HHT indicated that it was identical with malonaldehyde (compare refs. 7 and 8, and Fig. 1 ). Intake of two tablets of aspirin (648 mg) inhibited formation of HHT and PHD by more than 95%. In another experiment, aspirin and indomethacin were preincubated with platelet suspensions and were found to inhibit synthesis of HHT and PHD (Fig. 3) . This corroborated our earlier results concerning the inhibitory effect of these drugs on the formation of labeled HHT and PHD from [1-'4C] 4 .94 nmol of deuterated PHD, 14.9 nmol of deuterated PGE2, or 11.2 nmol of deuterated PGF2a were added. HETE, HHT, and PHD were determined as described in the text whereas PGE2 and PGF2a were determined as described by Green et al. (9) . A, HETE; 0-0 HHT; *, PHD; [l, PGE2; *, PGF2,a; X, PGG2 + PGH2.
As expected, aspirin also strongly suppressed formation of TBA-positive material (Table 1) . Accordingly, the TBA reaction may be used as a convenient assay method in the evaluation of new drugs impairing platelet function. The release of HETE was increased about 3-fold in platelets obtained from subjects given aspirin (Table 1) . Similarly, preincubation of platelet suspensions with aspirin (100 ug/ml) and indomethacin (1 ,sg/ml) resulted in a 3.1-to 3.4-fold stimulation of the release of HETE (Fig. 3) . This effect on the production of HETE was also seen in the previous study (4) in which [1-'4C]arachidonic acid was used. It is probable that on treatment with thrombin, a limited pool of free arachidonic acid suddenly becomes available to the lipoxygenase and the fatty acid cyclo-oxygenase involved in the synthesis of HETE and of HHT plus PHD, respectively (Fig. 1) . Blockade of the fatty acid cyclo-oxygenase by aspirin and indomethacin would make more arachidonic acid available to the lipoxygenase and result in increased formation of HETE.
Aspirin inhibits the second wave of platelet aggregation in vitro (10) (11) (12) and has an antihemostatic effect in vivo (13, HETE HHT\ 14) . Its effects on platelets include acetylation of proteins (15) and inhibition of prostaglandin formation (16) . However, among the classical prostaglandins, PGE1 has an inhibitory effect (17), PGF2a, no effect (17) and PGE2 a weak inhibitory (first phase) and stimulatory (second phase) effect (18) on platelet aggregation. Inhibition of the production of the prostaglandins PGE2 and PGF2., earlier known to be released during platelet aggregation, did not, therefore, satisfactorily explain the effect of aspirin on this process. Reports on the synthesis and blockade of arachidonic-acid-induced formation of an unidentified factor with aggregating properties have also appeared. These studies did not provide any structural information on the mechanism involved in the antiaggregating effect of aspirin (19) (20) (21) . The aggregating properties of the endoperoxides, PGG2 and PGH2, their release during aggregation, and the inhibition of their formation by aspirin led us to propose that the mechanism of action of aspirin was through inhibition of the platelet cyclooxygenase responsible for formation of PGG2 (1). The evidence for this mechanism is strongly amplified by the results reported here which demonstrate considerable release of endoperoxide metabolites during aggregation and inhibition of the release by aspirin.
The new concept emerging from the present study is that the prostaglandins can exert their biological action through the endoperoxides, and that these compounds may be metabolized almost exclusively to nonprostanoate structures and only to a small extent to the classical prostaglandins. We have also found that the endoperoxide metabolites described here can be released from several other tissuest and that the endoperoxides, in addition to their effects on platelets, have unique biological actions on, e.g., airway and vascular smooth muscle (22) and adipocyte ghosts (23 
